Updated: March 12, 2026
Tesamorelin Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

Summarize with AI
Learn about the most common tesamorelin (Egrifta) side effects — including injection site reactions, joint pain, and blood sugar changes — and when to contact your doctor.
If you have been prescribed tesamorelin (Egrifta SV or Egrifta WR) for HIV-associated lipodystrophy, it's important to understand what side effects to expect, which ones are common and manageable, and which ones require immediate medical attention. This guide is based on FDA-approved prescribing information and clinical trial data.
How Tesamorelin Works — and Why It Causes Side Effects
Tesamorelin stimulates your pituitary gland to produce more growth hormone (GH). GH then increases levels of IGF-1 (insulin-like growth factor 1) in the blood. This is what reduces the visceral fat around your organs. However, because growth hormone affects many systems in the body — including fluid balance, joints, metabolism, and blood sugar — elevating GH and IGF-1 can cause a range of side effects beyond the intended fat reduction.
Common Side Effects (Reported in More Than 1% of Patients)
The following side effects were reported in clinical trials. Most are mild to moderate and do not require stopping the medication:
Injection site reactions (25% of patients): Redness (erythema), itching, pain, irritation, bruising, or swelling at the injection site. Rotating your injection sites to different areas of the abdomen helps reduce these reactions.
Arthralgia (joint pain): Joint pain and stiffness are among the most commonly reported side effects. Usually affects the larger joints.
Pain in extremities: Arm or leg pain or discomfort.
Peripheral edema: Swelling in the hands, feet, or ankles due to fluid retention, related to GH's effect on fluid balance.
Myalgia: Muscle pain or aches.
Paresthesia and hypoesthesia: Numbness, tingling, or abnormal sensations — especially in the hands and wrists (can indicate carpal tunnel syndrome).
Carpal tunnel syndrome: Numbness and tingling in the hand or wrist caused by nerve compression. If wrist pain and numbness persist, tell your doctor.
Nausea and vomiting: Gastrointestinal symptoms occur in some patients.
Muscle spasms, stiffness, and swelling: Related to GH's effects on musculoskeletal tissues.
Serious Side Effects: When to Call Your Doctor Immediately
The following side effects are less common but require prompt medical attention. Contact your doctor or go to the emergency room if you experience any of these:
Signs of a serious allergic reaction: Hives, rash, swelling of the face or throat, difficulty swallowing, trouble breathing, fast heartbeat, or feeling faint. This occurred in about 4% of patients in clinical trials. Discontinue tesamorelin immediately and seek emergency care.
High blood sugar symptoms: Increased thirst, frequent urination, hunger, blurred vision, or dry mouth. Tesamorelin can cause glucose intolerance or worsen pre-existing diabetes. Regular glucose monitoring is important.
Signs of cancer recurrence: Tesamorelin increases IGF-1, a known growth factor. If you have a history of cancer or develop any new or unusual symptoms, tell your doctor immediately.
Severe swelling or fluid retention: Rapid or severe swelling, especially in the legs or abdomen.
Vision changes: If you have diabetic retinopathy, tesamorelin may worsen eye complications. Report any vision changes to your doctor promptly.
Important Safety Warnings
Do not use during pregnancy: Tesamorelin is FDA Pregnancy Category X — it can cause fetal harm. Use effective birth control during treatment. If you become pregnant, stop tesamorelin and tell your doctor immediately.
Antibody formation: About 49-56% of patients develop anti-tesamorelin antibodies over 26 weeks of treatment. In clinical trials, antibody formation did not significantly affect the drug's effectiveness or safety.
Monitoring Tests While on Tesamorelin
Your doctor will order regular lab tests while you are on tesamorelin: IGF-1 levels (to check for excess GH stimulation), fasting blood glucose and HbA1c (to monitor for diabetes), and periodic clinical assessments for fluid retention and carpal tunnel symptoms. Also see our guide on tesamorelin drug interactions to ensure no other medications you take will interact with it. If you have questions about filling your prescription, medfinder can help you find a specialty pharmacy that has it in stock near you.
Frequently Asked Questions
The most commonly reported side effects of tesamorelin (Egrifta SV, Egrifta WR) are arthralgia (joint pain), injection site reactions (redness, itching, pain), pain in extremities, peripheral edema (swelling), and myalgia (muscle pain). These were identified in Phase 3 clinical trials and most are mild to moderate.
Tesamorelin can cause glucose intolerance and may worsen pre-existing diabetes. Growth hormone increases insulin resistance, which can raise blood sugar. Your doctor will monitor your glucose and HbA1c levels before starting tesamorelin and throughout treatment. If you develop diabetes, your doctor may consider discontinuing the medication.
Tesamorelin increases IGF-1, a known growth factor, which raises theoretical concerns about cancer risk. The medication is contraindicated in patients with active malignancy. Patients with a history of cancer require careful evaluation before starting tesamorelin. The FDA has not established that tesamorelin causes cancer, but your doctor will monitor closely given the elevated IGF-1 levels.
Injection site reactions (redness, itching, pain) are common, occurring in about 25% of patients on tesamorelin in clinical trials compared to 14% on placebo. They often improve over time. Rotating injection sites to different areas of the abdomen with each daily injection is the most effective strategy to minimize these reactions.
If you experience signs of a serious allergic reaction — including hives, swelling of the face or throat, difficulty breathing, or rapid heartbeat — stop taking tesamorelin immediately and seek emergency medical care. Call 911 or go to the nearest emergency room. Report the reaction to your doctor and to the FDA at 1-800-FDA-1088.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Tesamorelin also looked for:
More about Tesamorelin
36,651 have already found their meds with Medfinder.
Start your search today.





